The DOI matches its Crossref record; 103 of the 105 references it cites were found in a registry or an index.
Standardisation framework for the Maudsley staging method for treatment resistance in depression
Open accessAbstract
BACKGROUND: Treatment-resistant depression (TRD) is a serious and relatively common clinical condition. Lack of consensus on defining and staging TRD remains one of the main barriers to understanding TRD and approaches to intervention. The Maudsley Staging Method (MSM) is the first multidimensional model developed to define and stage treatment-resistance in "unipolar depression". The model is being used increasingly in treatment and epidemiological studies of TRD and has the potential to support consensus. Yet, standardised methods for rating the MSM have not been described adequately. The aim of this report is to present standardised approaches for rating or completing the MSM. METHOD: Based on the initial development of the MSM and a narrative review of the literature, the developers of the MSM provide explicit guidance on how the three dimensions of the MSM--treatment failure, severity of depressive episode and duration of depressive episode-- may be rated. RESULT: The core dimension of the MSM, treatment failure, may be assessed using the Maudsley Treatment Inventory (MTI), a new method developed for the purposes of completing the MSM. The MTI consists of a relatively comprehensive list of medications with options for rating doses and provisions treatment for multiple episodes. The second dimension, severity of symptoms, may be assessed using simple instruments such as the Clinical Global Impression, the Psychiatric Status Rating or checklist from a standard diagnostic checklist. The standardisation also provides a simple rating scale for scoring the third dimension, duration of depressive episode. CONCLUSION: The approaches provided should have clinical and research utility in staging TRD. However, in proposing this model, we are fully cognisant that until the pathophysiology of depression is better understood, staging methods can only be tentative approximations. Future developments should attempt to incorporate other biological/ pathophysiological dimensions for staging.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Other instruments that capture and re- cord current and prior antidepressant regimens are the self- rated Massachusetts General Hos pital Antidepressant Treatment Response Questionnaire (ATRQ) 166 and the Maudsley Treatment Inventory 56 .”
From Treatment‐resistant depression: definition, prevalence, detection, management, and investigational interventions (2023) · cites this paper as [56]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2013) · doi:10.1176/appi.books.9780890425596 · Cited by 116,369
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817 · cited 9×
“The depressive syndrome was defined either using rating scales (for example, the Hamilton Rating Scale for Depression (HRSD) [38]) or a standard operationalized diagnostic system, such as the Diagnostic and Statistical Manual of Mental Disorders (DSM) [39].”
MethodInfluentialDiagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR)
American Psychiatric Association (2000) · doi:10.1176/appi.books.9780890423349 · Cited by 11,069
Rush, A. J., Trivedi, M. H., Wisniewski, S. R., Nierenberg, A. A., Stewart, J. W., Warden, D., Niederehe, G., Thase, M. E., Lavori, P. W., Lebowitz, B. D., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.11.1905 · Cited by 5,643
Early Identification of Refractory Epilepsy
Kwan, P., & Brodie, M. J. (2000) · New England Journal of Medicine · doi:10.1056/nejm200002033420503 · Cited by 5,204
Trivedi, M. H., Rush, A. J., Wisniewski, S. R., Nierenberg, A. A., Warden, D., Ritz, L., Norquist, G., Howland, R. H., Lebowitz, B., McGrath, P. J., et al. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.1.28 · Cited by 3,879 · cited 1×
“There is dearth of robust evidence supporting the superiority of employing switching compared with augmentation strategies [3, 15] as well as the type of treatment used [44, 53], while number of treatments sequentially failing to produce improvement seem indicative of increasing treatmentresistance [53, 56] and thus f…”
BackgroundFrank, E. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810330075011 · Cited by 1,959 · cited 9×
“The depressive syndrome was defined either using rating scales (for example, the Hamilton Rating Scale for Depression (HRSD) [38]) or a standard operationalized diagnostic system, such as the Diagnostic and Statistical Manual of Mental Disorders (DSM) [39].”
BackgroundInfluentialKeller, M. B. (1987) · Archives of General Psychiatry · doi:10.1001/archpsyc.1987.01800180050009 · Cited by 1,643 · cited 2×
“Thus, defining clinical remission may require scales, such as the LIFE-chart [67] that establish remission more explicitly.”
BackgroundKaplan & Sadock's Comprehensive Textbook of Psychiatry
Sadock, B. J., & Sadock, V. A. (2000) · Cited by 1,523
Diagnosis and definition of treatment-resistant depression
Fava, M. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00231-2 · Cited by 1,380 · cited 4×
“(DOC 348 kb) Abbreviations APA: American Psychiatric Association; ATHF: The Antidepressant Treatment History Form; ATRQ: Antidepressant Response Questionnaire; BAP: British Association for Psychopharmacology; CDT: Africa-Centre for Innovative Drug Development and Therapeutic Trials for Africa; CGI: Clinical Global Imp…”
BackgroundMethodResultInfluential
Research works printed but not linked: 6
- Helmchen H. Therapy-resistant depression: symptoms and syndromes. Contributions to symptomatology and syndromes. Pharmakopsychiatr Neuropsychopharmakol. 1974;7(3):139–44. · DOI
- National Institute for Health and Clinical Excellence: Clinical guideline 23 (amended) depression: management of depression in primary and secondary care. In.: National Institute for Health and Clinical Excellence; 2007: 34.
- Charney DS, Miller HL, Licinio J, Salomon R. Treatment of depression. In: Schatzberg AF, Nemeroff CB, editors. The American textbook of psychopharmacology. Washington, DC: American Psychiatric Press, Inc; 2005. p. 588.
- Centers for Medicare and Medicaid Services: Medicare Evidence Development & Coverage Advisory Committee: Panel Proceedings. In: 2016; Baltimore, Maryland: Centers for Medicare and Medicaid Services; 2016.
- World Health Organisation. The ICD-10 classification of mental and Behavioural disorders clinical descriptions and diagnostic guidelines 10th edn. Geneva: WHO; 1992.
- Taylor D, Paton C, Kapur S. The Maudsley prescribing guidelines in psychiatry 12th edn. London: Wiley-Blackwell; 2015.
Cited by
McIntyre, R. S., Alsuwaidan, M., Baune, B. T., Berk, M., Demyttenaere, K., Goldberg, J. F., Gorwood, P., Ho, R., Kasper, S., Kennedy, S. H., et al. (2023) · World Psychiatry · doi:10.1002/wps.21120 · Cited by 836
McAllister-Williams, R. H., Arango, C., Blier, P., Demyttenaere, K., Falkai, P., Gorwood, P., Hopwood, M., Javed, A., Kasper, S., Malhi, G. S., et al. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.02.023 · Cited by 278
Sforzini, L., Worrell, C., Kose, M., Anderson, I. M., Aouizerate, B., Arolt, V., Bauer, M., Baune, B. T., Blier, P., Cleare, A. J., et al. (2022) · Molecular Psychiatry · doi:10.1038/s41380-021-01381-x · Cited by 214
“A more structured method is to use staging models [6, 58], such as the Thase and Rush method [59], the Massachusetts General Hospital Staging model (MGH-s) [22], and the more recent Maudsley Staging Model (MSM) [60], which also allows Molecular Psychiatry (2022) 27:1286 – 1299 the assessment of previous antidepressant…”
MethodSelf-citationAugmentation therapies for treatment-resistant depression: systematic review and meta-analysis
Strawbridge, R., Carter, B., Marwood, L., Bandelow, B., Tsapekos, D., Nikolova, V. L., Taylor, R., Mantingh, T., de Angel, V., Patrick, F., et al. (2019) · British Journal of Psychiatry · doi:10.1192/bjp.2018.233 · Cited by 140
“British Journal of Psychiatry, 214(1), 42-51.”
Self-citationRandomized trial of ketamine masked by surgical anesthesia in patients with depression
Lii, T. R., Smith, A. E., Flohr, J. R., Okada, R. L., Nyongesa, C. A., Cianfichi, L. J., Hack, L. M., Schatzberg, A. F., & Heifets, B. D. (2023) · Nature Mental Health · doi:10.1038/s44220-023-00140-x · Cited by 137
“At screening, both groups had moderate levels of depression as rated by the Montgomery–Åsberg Depression Rating Scale (MADRS; mean score for ketamine, 27.7, and placebo, 30.6) and moderate levels of treatment resistance as measured by the Maudsley staging method (MSM; mean score for ketamine, 8.3, and placebo, 7.5).”
Influential
Metadata
- Authors
- Fekadu, A., Donocik, J. G., & Cleare, A. J.
- Affiliations
- Brighton and Sussex Medical School (GB)
- King's College London (GB)
- Corresponding author
- Fekadu, Abebaw
- Venue
- BMC Psychiatry
- Published
- 2018-04-11
- Volume
- 18
- Issue
- 1
- Pages
- 100-100
- ISSN
- 1471-244X (ISSN-L)
- PMC
- PMC5896127
- OpenAlex
- W2796957480
- Cited by
- 106
- References
- 105
- Citations by year
- 2026: 19 · 2025: 16 · 2024: 9 · 2023: 17 · 2022: 10 · 2021: 14 · 2020: 9 · 2019: 10 · 2018: 2
- FWCI
- 5.65
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0/ (tdm)
- Locations
- BMC Psychiatry (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Research Portal (King's College London) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Sussex Research Online (University of Sussex) (submittedVersion, cc-by)
- Funders
- No funding source for this work
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Keywords
- treatment-resistant depression, treatment failure, depressive episode severity, depressive episode duration, major depressive disorder, rating scales
- MeSH terms
- Humans, Models, Psychological, Psychiatric Status Rating Scales, Practice Guidelines as Topic, Depressive Disorder, Treatment-Resistant
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Standardisation framework for the Maudsley staging method for treatment resistance in depression. https://app.cochat.ai/papers/10.1186/s12888-018-1679-x
- The paper
- Fekadu, A., Donocik, J. G., & Cleare, A. J. (2018). Standardisation framework for the Maudsley staging method for treatment resistance in depression. BMC Psychiatry. https://doi.org/10.1186/s12888-018-1679-x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
